Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $1.05
67% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $524.0K |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $38.1K | $158.1K |
| Gross profit | $0 | $0 | $0 | $0 | $0 | $0 | −$38.1K | $365.9K |
| Gross margin | — | — | — | — | — | — | — | 69.8% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$143.0K | −$152.0K | −$208.0K | −$146.0K | −$141.0K | −$141.0K | −$210.7K | −$809.9K |
| EBITDA | −$143.0K | −$446 | −$208.0K | −$282 | $35 | −$5.3K | −$172.6K | −$651.8K |
| Net income | −$178.0K | $426.6K | −$209.0K | −$148.0K | −$145.0K | −$146.0K | −$212.6K | −$860.7K |
| Net margin | — | — | — | — | — | — | — | -164.3% |
| EPS (diluted) | -0.07 | 0.13 | -0.04 | -0.03 | -0.03 | -0.03 | -0.00 | -0.01 |
Annual figures · source: Financial Modeling Prep
HST GLOBAL INC
No one on the platform currently holds HSTC.
No tracked institution reports a position in HSTC as of their last filing.
| Execution date | Ratio |
|---|---|
| 2019-11-26 | 1-for-15reverse |
No one on the platform has traded HSTC yet.
| $8180 |
| — |
| INFIQInfinity Pharmaceuticals, Inc. | $0.00 | +0.00% | $9076 | — |
| LIFSLife Stem Genetics Inc. | $0.00 | +0.00% | $4584 | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.